- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Post-acute Respiratory Complications of COVID-19 in Argentina
Total 120 results
-
National Institute of Environmental Health Sciences...CompletedRetinopathy of Prematurity | Pulmonary Disease | Bronchopulmonary Dysplasia | PrematurityUnited States, Argentina
-
CanSino Biologics Inc.Beijing Institute of BiotechnologyCompletedCOVID-19Mexico, Argentina, Chile, Pakistan, Russian Federation
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID)CompletedCOVID-19 | SARS-CoV-2United States, Malawi, Zimbabwe, Botswana, South Africa, Zambia, Argentina, Brazil, Mexico, Peru, Tanzania
-
Invivyd, Inc.TerminatedCOVID-19Argentina, Brazil, Bulgaria, Germany, Greece, Hungary, Moldova, Republic of, Poland, Romania, South Africa, Ukraine
-
AmgenCompletedCOVID-19United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Saint Luke's Health SystemAstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas CityCompletedCOVID-19United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
-
Invivyd, Inc.TerminatedCOVID-19United States, Argentina, Czechia, Georgia, Germany, Moldova, Republic of, Poland, Romania, Ukraine
-
Eli Lilly and CompanyCompletedCOVID-19United States, Spain, India, Germany, Puerto Rico, Brazil, Korea, Republic of, Argentina, Italy, Japan, Mexico, Russian Federation, United Kingdom
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
Daniel BenjaminNational Center for Advancing Translational Sciences (NCATS); Biomedical Advanced...CompletedCovid19United States, Brazil, Argentina, Mexico, Peru
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Kirby InstituteViiV Healthcare; University of Witwatersrand, South Africa; University of Liverpool and other collaboratorsCompletedCoronavirus Infection | HIV-infection/AidsUganda, Cameroon, Argentina, Brazil, India, Malaysia, Nigeria, South Africa, Thailand, Zimbabwe